Filing Details
- Accession Number:
- 0001140361-10-012102
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-03-16 13:00:00
- Reporting Period:
- 2010-03-15
- Filing Date:
- 2010-03-16
- Accepted Time:
- 2010-03-16 11:06:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
821995 | Columbia Laboratories Inc | CBRX | Pharmaceutical Preparations (2834) | 592758596 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1282199 | Jr Frank Condella | 354 Eisenhower Parkway Plaza I Second Floor Livingston NJ 07039 | Interim Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
$.01 Par Value Common Stock | Acquisiton | 2010-03-15 | 100,000 | $1.12 | 162,764 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $1.09 to $1.15. The price reported above reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.